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Background: The purpose of our study is to investigate differences in normative
PROMIS upper extremity function (PROMIS-UE), physical function (PROMIS-PF),
and pain interference (PROMIS-PI) scores across age cohorts in individuals without upper extremity disability.
Methods: Individuals without upper extremity disability were prospectively
enrolled. Subjects were administered PROMIS-UE, PROMIS-PF, and PROMIS-PI
forms. Retrospective PROMIS data for eligible subjects were also utilized. The
enrolled cohort was divided into age groups: 20–39, 40–59, and 60–79 years old.
ANOVA, ceiling and floor effect analysis, and kurtosis and skewness statistics were
performed to assess PROMIS scores trends with age.
Results: This study included 346 individuals. In the 20–39 age group, mean
PROMIS scores were 56.2 ± 6.1, 59.8 ± 6.9, and 43.1 ± 6.7 for PROMIS-UE,
PROMIS-PF, and PROMIS-PI, respectively. In the “40–59” age group, mean
PROMIS computer adaptive test scores were 53.3 ± 7.5, 55.3 ± 7.6, and 46.6 ± 7.8 for
PROMIS-UE, PROMIS-PF, and PROMIS-PI, respectively. In the 60–79 age group,
mean PROMIS scores were 48.4 ± 7.6, 48.5 ± 5.6, and 48.7 ± 6.9 for PROMIS-UE,
PROMIS-PF, and PROMIS-PI, respectively. Differences in mean PROMIS scores
were significant across all PROMIS domains and age cohorts (P < 0.001).
Conclusion: Younger individuals without hand or upper extremity disability show
higher normative PROMIS-UE and PROMIS-PF scores and lower PROMIS-PI
scores, indicating greater function and less pain than older counterparts. A universal reference PROMIS score of 50 appears suboptimal for clinical assessment and
decision-making in the hand and upper extremity clinic. (Plast Reconstr Surg Glob
Open 2021;9:e3768; doi: 10.1097/GOX.0000000000003768; Published online 17 August
2021.)

INTRODUCTION

Patient-reported Outcomes Measurement Information
System (PROMIS) is a patient-reported outcome measure
(PROM) developed by the National Institutes of Health.1
PROMIS has become widely utilized in clinical practices
due to its increased precision and limited floor and ceiling
effects.2–5 PROMIS computer adaptive tests (CAT) apply
computer-based algorithms to choose questions from an
item bank, leading to shorter forms containing a select
number of items.1,6 PROMIS CAT forms encompass health
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domains such as upper extremity function (PROMIS-UE),
physical function (PROMIS-PF), and pain interference
(PROMIS-PI) and are commonly utilized in assessing
hand and upper extremity patients.7–10 PROMIS-UE has
been shown to most effectively capture larger changes in
upper extremity function, whereas PROMIS-PF also correlates with established upper extremity PROMs such as
the Disabilities in Arm, Shoulder, and Hand (DASH) metric.4,11,12 Moreover, the extent to which pain inhibits quality of life in hand and upper extremity patients is strongly
represented by PROMIS-PI.13
Patients’ preoperative or pretreatment PROMIS
scores can be used in hand and upper extremity clinics to
determine whether the minimal clinically important difference (MCID) is attained after surgeries such as carpal
tunnel release or treatment of conditions such as distal
radius fractures.14,15 Achievement of MCID can serve as
an indicator of the effectiveness of surgical and nonoperative interventions. For example, a patient who undergoes a carpal tunnel release who achieves a preoperative
to postoperative PROMIS-UE score improvement of +5.0
Disclosure: The authors have no financial interest to declare
in relation to the content of this article.

www.PRSGlobalOpen.com

1

PRS Global Open • 2021
that exceeds the established MCID of 3.6 for PROMIS-UE
can be said to have achieved MCID and significant clinical improvement.14 Commonly, many hand and upper
extremity surgeons identify patients with initial PROMIS
scores deviating from 50 for surgery or treatment, as this
score is assumed to be the “normative” value of a healthy
reference population.8 However, previous research indicates that PROMIS and other comparable metrics such as
the DASH and Knee Injury and Osteoarthritis Outcomes
Score differ by age, so this reference score presents potential limitations.16–19 Determining age-calibrated PROMIS
reference scores is therefore important in evaluating
patient candidacy for surgical procedures and better interpreting MCID.
Normative PROMIS scores have previously been shown
to deviate from 50 for healthy, asymptomatic individuals
both above and below 40 years of age.8 Although this is
a significant finding, a considerable portion of hand and
upper extremity diagnoses tend to affect patients above
the age of 40.20–25 Thus, improved determination of normative PROMIS scores across more specific age ranges
within this increasingly afflicted over 40 cohort is merited,
as these individuals are more frequently seen by hand and
upper extremity clinicians and likely to undergo surgery.
Clarification of age-calibrated PROMIS scores can optimize the utility and accuracy of PROMIS in assessing and
treating this disproportionately affected older population.
The purpose of our study is to investigate differences
in normative PROMIS-UE, PROMIS-PF, and PROMIS-PI
scores across age cohorts in individuals without upper
extremity disability. We hypothesize that younger individuals will have higher PROMIS-UE and PROMIS-PF
scores representative of increased function and lower
PROMIS-PI scores indicative of decreased pain levels in
comparison to older counterparts.

MATERIALS AND METHODS

Institutional review board approval was attained before
commencing this study, and no grant support or research
funding was provided. Participants were prospectively
recruited from October 20, 2020, to November 15, 2020.
Subjects meeting inclusion criteria (20 years of age or
older, without any stated symptoms of pain or disability
in the upper extremity) and exclusion criteria (under 20
years of age, exhibiting upper extremity complaint or disability, refusal to complete all PROMIS CAT forms) were
contacted for enrollment in the study by the authors
through in-person requests at public spaces as well as
phone, e-mail, and in-person solicitation of peers and colleagues. Retrospective PROMIS data for subjects meeting
inclusion and exclusion criteria stored on an institutionwide Research Electronic Data Capture (REDcap) registry
was also utilized in analysis. REDcap is a web-based HIPAAcompliant data management and collection application
maintained by Vanderbilt University (Nashville, Tenn.).26
PROMIS CAT forms for the domains of upper
extremity function (PROMIS-UE), physical function
(PROMIS-PF), and pain interference (PROMIS-PI) were
e-mailed or administered in-person on an electronic
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device using REDCap to enrolled subjects. Participants
were also asked about their age in years, and up to
two reminders were sent via repeat e-mail message. All
PROMIS instruments were calibrated to a mean score
of 50 and an SD of 10. Higher scores on PROMIS-UE
and PROMIS-PF forms signify greater physical function,
whereas higher scores on the PROMIS-PI form indicate
that pain has a greater detriment on quality of life. The
enrolled cohort was divided into age groups: 20–39 years
old, 40–59 years old, and 60–79 years old. Prior research
regarding normative PROMIS scores only assessed subjects in two groups above 40 years and below 40 years.8
With consideration to this previous work, we deemed
that classifying subjects in 20-year age brackets between
the ages of 20 and 79 years would be the most optimal
methodology for evaluating normative PROMIS scores
with respect to life expectancy.
Power analysis was additionally performed for the
study. Assuming an ANOVA F-test with a 0.05 alpha and
an effect size of 0.25, no fewer than 207 subjects in total
(69 subjects in each age group) must be tested to detect a
significant difference in PROMIS scores among the three
age groups with a power of 80%.
Statistical Methods

Descriptive statistics were calculated and reported.
One-way analysis of variance (ANOVA) was used to identify significant differences in PROMIS domain scores
among the three age groups. Despite PROMIS being
designed to be normally distributed, intragroup correlations between PROMIS instruments were determined
using Spearman rho (r). Similar to previous studies,
Spearman correlation strengths were categorized as
excellent (>0.7), excellent-good (0.61 to 0.70), good
(0.4 to 0.6), or poor (<0.4).27 Histograms were visually
analyzed, as frequency polygons, for floor and ceiling
effects, which measure the ability of a questionnaire
to differentiate amongst those respondents at both
extremes of the scale.
Additionally, ceiling and floor effects for all three age
group PROMIS CAT forms were determined by calculating the number of individuals who had PROMIS scores
toward the maximum and minimum scores possible and
dividing it by the total number of individuals in the study
cohort. As previously reported, a true floor or ceiling
effect was considered present if 15% or more of subjects
were at either of the extremes.8 Kurtosis and skewness test
statistics were also obtained and divided by their respective
standard errors of measurement to determine normality,
respective to each statistic. Values outside the range of
−1.96 to 1.96 were considered nonnormal.
For all analyses, significance was set a priori at
a P value less than 0.05. Statistical analyses were conducted
using SPSS software (IBM Corp. Released 2017. IBM SPSS
Statistics for Windows, Version 25.0. Armonk, N.Y.)

RESULTS

This study included 346 participants that completed
all the necessary PROMIS questionnaires. Of this cohort,
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176 were between the age of 20 and 39 (mean age = 25.5),
96 were between the age of 40 and 59 (mean age = 49.9),
and 74 were between the age of 60 and 79 (mean age =
68.6). In the 20–39 age group, mean PROMIS CAT scores
were 56.2 ± 6.1, 59.8 ± 6.9, and 43.1 ± 6.7 for PROMIS-UE,
PROMIS-PF, and PROMIS-PI, respectively (Table 1). In the
40–59 age group, mean PROMIS CAT scores were 53.3 ±
7.5, 55.3 ± 7.6, and 46.6 ± 7.8 for PROMIS-UE, PROMIS-PF,
and PROMIS-PI, respectively (Table 1). In the 60–79 age
group, mean PROMIS CAT scores were 48.4 ± 7.6, 48.5
± 5.6, and 48.7 ± 6.9 for PROMIS-UE, PROMIS-PF, and
PROMIS-PI, respectively (Table 1). Differences in mean
PROMIS scores were statistically significant across all
PROMIS domains and age cohorts (P < 0.001). Median
scores and interquartile ranges (IQRs) for PROMIS CAT
scores by age group can also be found in Table 1.
Floor and ceiling effects and score distributions of each
cohort were visualized with histogram analysis (Figs. 1–3).
PROMIS-UE showed significant ceiling effects in all age
cohorts while PROMIS-PI showed strong floor effects in
all cohorts (Table 2). Both findings were most prominent
in the 40–59 cohort (35.5% and 40.9%, respectively) when
compared to the 20–39 and 60–79 cohorts (Table 2).
Distribution analysis identified normality for PROMIS-UE,
PROMIS-PF, and PROMIS-PI in the 60–79 cohort when
assessed by skewness and kurtosis (Table 2). Normality was
also observed for PROMIS-PF in the 20–39 and 40–59 age
cohorts when assessed by skewness and kurtosis (Table 2).
PROMIS-UE showed a good correlation with
PROMIS-PF in the 20–39 age cohort (r = 0.402, P < 0.01).
In this same cohort, poor correlations were observed when
comparing PROMIS-PI with PROMIS-UE and PROMIS-PF
(r = −0.364, P < 0.01; r = −0.388, P < 0.01, respectively)
(Table 3). In the 40–59 age cohort, good correlations were
observed when comparing PROMIS-UE with PROMIS-PF
and PROMIS-PI (r = −0.550, P < 0.01; r = 0.535, P < 0.01,
respectively). In this same cohort, good-excellent correlations were found when comparing PROMIS-PF with
PROMIS-PI (r = −0.607, P < 0.01) (Table 3). In the 60–79
age cohort, a good correlation was observed when comparing PROMIS-PI with PROMIS-UE and PROMIS-PF
(r = −0.438, P < 0.01; r = −0.499, P < 0.01, respectively).
In this same cohort, excellent correlations were found
between PROMIS-UE and PROMIS-PF (r = 0.701, P <

Table 1. Median Scores and IQRs of PROMIS CAT Domains
by Age Group
PROMIS
CAT Domain
PROMIS-UE

PROMIS-PF

PROMIS-PI

Age
Group (y)

Mean t Score ± SD
(Min–Max)

Median t
Score ± IQR

20–39
40–59
60–79

56.2 ± 6.1 (14.7–61.0)
53.3 ± 7.5 (27.1–61.0)
48.4 ± 7.6 (27.1–61.0)

61.0 ± 9.1
54.5 ± 12.4
47.5 ± 11.3

20–39
40–59
60–79

59.8 ± 6.9 (14.7–75.6)
55.3 ± 7.6 (37.2–75.6)
48.5 ± 5.6 (35.5–68.5)

60.4 ± 8.5
54.8 ± 10.7
48.5 ± 5.6

20–39
40–59
60–79

43.1 ± 6.7 (38.7–83.8)
46.6 ± 7.8 (38.7–76.4)
48.7 ± 6.9 (38.7-–67.0)

38.7 ± 11.2
46.6 ± 13.9
50.1 ± 7.4

Fig. 1. PROMIS score distribution of individuals 20–39 with no upper
extremity disability or pain. Percentage frequency of PROMIS-UE,
PROMIS-PF, and PROMIS-PI scores in the enrolled 20–39 age cohort
(n = 176) are displayed.

0.01) (Table 3). No significant correlations were found
between age and any PROMIS domain for any of the three
age cohorts analyzed.

DISCUSSION

As hypothesized, this study demonstrates how younger
individuals show higher normative PROMIS-UE and
PROMIS-PF scores as well as lower PROMIS-PI scores, indicating higher function and less pain when compared to
older counterparts. PROMIS-PF and PROMIS-UE scores in
individuals without upper extremity disability are the highest in the 20–39 cohort, followed by the 40–59 and then
60–79 cohort. Mean PROMIS-PF and PROMIS-UE scores
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Fig. 2. PROMIS score distribution of individuals 40–59 with no upper
extremity disability or pain. Percentage frequency of PROMIS-UE,
PROMIS-PF, and PROMIS-PI scores in the enrolled 40–59 age cohort
(n = 96) are shown.

in both the 20–39 cohort (56.2 and 59.8, respectively) as
well as the 40–59 cohort (53.3 and 55.3) exceeded the reference PROMIS score of 50, whereas those in the 60–79
cohort (48.4 and 48.5) were lower than 50. PROMIS-PI
scores in individuals without upper extremity disability are
highest in the 60–79 cohort, followed by the 40–59 and
then 20–39 cohorts. Mean PROMIS-PI scores in the 20–39,
40–59, and 60–79 cohorts were all below the reference
PROMIS score of 50 (43.1, 46.6, and 48.7, respectively).
Given the significant age-based differences in pain and
function in healthy individuals without upper extremity disability, a universal reference PROMIS score of 50 may not
be accurate for clinical comparison in the hand and upper
extremity clinic, especially when evaluating the need for surgery. For example, a 58-year-old patient with carpal tunnel
syndrome and an initial PROMIS-PF score of 53.0 may not be
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Fig. 3. PROMIS score distribution of individuals 60–79 with no upper
extremity disability or pain. Percentage frequency of PROMIS-UE,
PROMIS-PF, and PROMIS-PI scores in the enrolled 60–79 age cohort
(n = 74) are visualized.

deemed a candidate for a carpal tunnel release because the
patient already exceeds the currently established reference
score of 50. When looking at age-calibrated PROMIS-UE reference scores determined in our study, however, this patient
does not meet the reference score of 55.3 for the 40–59
cohort and thus could potentially be considered for surgery based on this interpretation. Age-calibrated PROMIS
scores can also better contextualize how MCID relates to
clinical improvement in patients. For instance, a 35-year-old
patient who undergoes a carpal tunnel release and achieves
a preoperative to postoperative PROMIS-UE score change
of 46.0–51.0 can be said to have achieved MCID because
the improvement of +5.0 exceeds the established MCID
of 3.6 for PROMIS-UE.14 Though this patient has met the
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Table 2. Distribution Analysis of PROMIS CAT Domains by Age Group
Age 20 to 39

PROMIS
CAT Domain
PROMIS-UE

PROMIS-PF

PROMIS-PI

Statistic

Value

Kurtosis
Skewness
Floor effect, n (%)
Ceiling effect, n (%)

0.314
−1.110

Kurtosis
Skewness
Floor effect, n (%)
Ceiling effect, n (%)

0.370
−0.219

Kurtosis
Skewness
Floor effect, n (%)
Ceiling effect, n (%)

−0.185
1.137

SEM

Age 40 to 59

Normality

Value

0.359
0.875
0.181
−6.133
1 (0.3%)
96 (26.5%)

−0.759
0.133

1.031
−1.210

0.433
0.302

0.359
−0.515
0.181
6.282
121 (33.4%)
0 (0.0%)

0.711
0.693

0.359
0.181
1 (0.3%)
6 (1.7%)

SEM

Age 60 to 79

Normality

Value

0.250
−3.036
0.495
0.269
0 (0.0%)
33 (35.5%)

0.106
−0.302

0.250
0.495
0 (0.0%)
3 (3.2%)

1.732
0.610

0.414
1.902

0.250
0.495
38 (40.9%)
1 (0.3%)

2.844
1.400

0.039
−0.365

SEM

Normality

0.283
0.375
0.559
−0.540
1 (0.3%)
11 (15.3%)
1.463
3.403

0.283
0.559
0 (0.0%)
0 (0.0%)

0.283
0.137
0.559
−0.653
17 (23.6%)
0 (0.0%)

PF, physical function; SEM, standard error of measurement.
Boldface values indicate statistical test values within normal distribution assumption (–1.96 to 1.96).

technical definition for attaining MCID and has a postoperative PROMIS-UE score above 50, the score of 51.0 is still
lower than the age-calibrated PROMIS-UE reference score
of 56.2 determined in our study. Essentially, this patient has
a lower level of function compared to healthy individuals
in the same age cohort despite achievement of MCID suggesting otherwise. These scenarios emphasize the value of
utilizing age-calibrated PROMIS scores in clinical decisionmaking and evaluation of outcomes.
A previous study at a Midwest academic medical center also looked at normative PROMIS scores in asymptomatic subjects.8 This study enrolled 294 individuals and
compared normative PROMIS scores in those under 40
years or aged 40 years and above, revealing how average
PROMIS-UE (55.9 versus 51.2) and PROMIS-PF (59.7 versus 52.9) scores were significantly higher in younger subjects while PROMIS-PI scores were significantly higher in
older counterparts (49.0 versus 43.6). Our study finds similarly decreasing trends of PROMIS-UE and PROMIS-PF
with age and an increase in PROMIS-PI with age. For
individuals over 60 years, mean PROMIS-UE, -PF, and -PI
scores were, respectively, 48.4, 48.5, and 48.7, whereas

scores for those below 40 years were 56.2, 59.8, and 43.1.
Our study supports previous findings regarding how
younger individuals have increased function and less pain
in comparison to older counterparts. Moreover, our study
better discerns differences in normative PROMIS scores
across age cohorts. By looking at more specific 20-year-age
intervals instead of broader 40-year intervals, we provide
detailed insights into specific normative PROMIS scores
that can be better utilized in clinic settings.
Though not entirely similar to our investigation, previous research at a tertiary care upper extremity clinic in St.
Louis assessed the relationship between PROMIS scores
and age in outpatients.3 In this study, advancing age demonstrated a weak negative correlation with PROMIS-PF
and PROMIS-UE in upper extremity patients. Likewise,
another study at an academic medical center in Utah analyzed correlations between PROMIS domains in hand and
upper extremity patients.10 Findings show how PROMIS-PF
and PROMIS-UE were strongly negatively correlated
with PROMIS-PI in upper extremity patients. Like both
of the aforementioned studies, we also analyze PROMIS
trends related to age and correlations between different

Table 3. Correlations of PROMIS CAT Domains by Age Group
PROMIS
CAT
Domain
PROMIS-UE

PROMIS-PF

PROMIS-PI

Total Cohort

Age 20−49

Age 40−59

Comparative
Measure

R
Value

PROMIS-PF
PROMIS-PI
Age

0.582 <0.01
−0.464 <0.01
−0.388 <0.01

Good
Good
Poor

0.402
−0.364
0.017

<0.01
<0.01
0.817

Good
Poor
Poor

0.535
−0.550
−0.129

<0.01
<0.01
0.218

PROMIS-UE
PROMIS-PI

0.582 <0.01
−0.549 <0.01

Good
Good

0.402
−0.388

<0.01
<0.01

Good
Poor

0.535
−0.607

<0.01
<0.01

Age

−0.544 <0.01

Good

−0.062

Poor

−0.24

PROMIS-UE
PROMIS-PF

−0.464 <0.01
−0.549 <0.01

Good
Good

−0.364
−0.388

Poor
Poor

−0.550
−0.607

0.318 <0.01

Poor

0.120

Poor

−0.115

Age

P

Correlation
R
Strength
Value

P

0.406
<0.01
<0.01
0.109

Correlation
R
Strength Value

P

Age 60−79

Correlation
R
Strength
Value
Good
Good
Poor

P

Correlation
Strength

0.701 <0.01 Excellent
−0.438 <0.01
Good
−0.257 0.029 Poor

Good
0.702 <0.01 Excellent
Excellent- −0.499 <0.01
Good
Good
0.821
Poor
−0.139 0.246 Poor

<0.01
<0.01

Good
−0.438 <0.01
Excellent- −0.499 <0.01
Good
0.272
Poor
−0.151 0.204

Good
Good
Poor

PF, physical function.
Boldface values indicate statistically significant values (p < 0.05).
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PROMIS domains. However, we evaluate these relationships in healthy individuals instead of patients with hand
and upper extremity diagnoses as the other two studies
do. Though our research has a similar direction, drawing
comparisons between our findings and the St. Louis and
Utah studies is not feasible given the fundamental differences in the health of our enrolled cohorts.
This investigation has multiple limitations. First, our
study does not evaluate differences in demographics
across the enrolled cohort other than age. Such analysis
would have allowed for deeper insights into the variance
in normative PROMIS according to additional relevant
factors such as race and gender. Regardless, age is still an
important criterion for calibrating normative PROMIS
scores with clinical applications, even in the absence of
other comparisons. Second, some enrolled individuals may not have entirely met inclusion criteria, thereby
skewing responses. For example, certain subjects may
have perceived themselves as having no upper extremity
disability and thus completed PROMIS CAT forms, even
though their actual physical condition reflected otherwise. However, enrolled subjects were explained eligibility
criteria in great detail by researchers and allowed to ask
questions, which likely limits the degree of improper form
completion. Third, our study presents a limited diversity
of enrolled individuals. The majority of participants were
from a specific metropolitan area, leading to homogeneity in the data that limits the external validity. However,
many contacts located in different geographic regions
were also enrolled, which improves this potential lack of
generalizability.
Our study better clarifies age-calibrated PROMIS
scores of clinical relevance to hand and upper extremity
patients. We show how these normative PROMIS scores
range between 43.1 and 59.8 across all age cohorts and
PROMIS domains, which is notable given how MCID for
many conditions in this patient population is often below
5.0.14,15 Thus, age-calibrated PROMIS scores are critical
to better assessing and treating patients in the hand and
upper extremity clinic.
Charles S. Day, MD, MBA
Department of Orthopedic Surgery
Henry Ford Health System
2799 W. Grand Blvd., CFP-6
Detroit, MI 48202
E-mail: cday9@hfhs.org
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